XORTX Therapeutics Inc (XRTX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.319x

Based on the latest financial reports, XORTX Therapeutics Inc (XRTX) has a cash flow conversion efficiency ratio of -0.319x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-629.62K ≈ $-455.46K USD) by net assets (CA$1.97 Million ≈ $1.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See XORTX Therapeutics Inc (XRTX) defensive interval to measure how many days the company can operate on defensive assets alone.

XORTX Therapeutics Inc - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how XORTX Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

XORTX Therapeutics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of XORTX Therapeutics Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Madhav Marbles and Granites Limited NSE:MADHAV	-0.005x
Industronics Bhd KLSE:9393	-0.423x
ZEUS Resources Ltd AU:ZEU	-0.114x
Saferoads Holdings Ltd AU:SRH	-0.110x
Alakasa Industrindo Tbk JK:ALKA	0.034x
BELLUSCURA PLC LS -01 F:9VQ	N/A
Activate Energy Acquisition Corp. Warrant NASDAQ:AEAQW	N/A
Oriental Culture Holding Ltd NASDAQ:OCG	0.009x

Annual Cash Flow Conversion Efficiency for XORTX Therapeutics Inc (2018–2024)

The table below shows the annual cash flow conversion efficiency of XORTX Therapeutics Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see XORTX Therapeutics Inc (XRTX) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$3.34 Million ≈ $2.41 Million	CA$-3.68 Million ≈ $-2.66 Million	-1.103x	+22.26%
2023-12-31	CA$4.64 Million ≈ $3.36 Million	CA$-6.58 Million ≈ $-4.76 Million	-1.418x	+17.35%
2022-12-31	CA$6.97 Million ≈ $5.05 Million	CA$-11.97 Million ≈ $-8.66 Million	-1.716x	-373.73%
2021-12-31	CA$16.74 Million ≈ $12.11 Million	CA$-6.06 Million ≈ $-4.39 Million	-0.362x	+37.53%
2020-12-31	CA$1.26 Million ≈ $908.75K	CA$-728.40K ≈ $-526.91K	-0.580x	-149.19%
2019-12-31	CA$-211.72K ≈ $-153.16K	CA$-249.58K ≈ $-180.54K	1.179x	+124.37%
2018-12-31	CA$321.54K ≈ $232.60K	CA$-1.56 Million ≈ $-1.13 Million	-4.837x	--

About XORTX Therapeutics Inc

V:XRTX Canada Biotechnology

Market Cap

$15.26 Million

CA$21.10 Million CAD

Market Cap Rank

#29197 Global

#1381 in Canada

Share Price

CA$3.03

Change (1 day)

+1.00%

52-Week Range

CA$0.49 - CA$3.96

All Time High

CA$387.99